Source:http://linkedlifedata.com/resource/pubmed/id/15305378
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2004-8-12
|
pubmed:abstractText |
We previously demonstrated that expression of androgen receptor (AR) by transfection of the androgen-independent prostate cancer cell line PC3 decreases invasion and adhesion of these cells (PC3-AR) through modulation of alpha6beta4 integrin expression. The treatment with androgens further reduced invasion of the cells without modifying alpha6beta4 expression, suggesting an interference with the invasion process by androgens. Here, we investigated EGF-mediated signal transduction processes that lead to invasion in PC3-AR cells. We show that EGF-induced EGFR autotransphosphorylation is reduced in PC3-AR cells compared to PC3 cells transfected only with the vector (PC3-Neo). EGF-stimulated PI3K activity, a key signaling pathway for invasion of these cells, and EGF-PI3K interaction are also decreased in PC3-AR cells and further reduced by treatment with androgen. Finally, we show that EGFR internalization process was reduced in PC3-AR and LNCaP cells compared to PC3-Neo. Investigations on the location of AR in PC3-AR transfected cells were also conducted. Immunoconfocal microscopy and coimminoprecipitation studies demonstrated the presence of an interaction between EGFR and AR at membrane level in PC3-AR and LNCaP cells. In conclusion, our results suggest that the expression of AR by transfection in PC3 cells confers a less-malignant phenotype by interfering with EGFR signaling leading to invasion through a mechanism involving an interaction between AR and EGFR.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0020-7136
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 2004 Wiley-Liss, Inc.
|
pubmed:issnType |
Print
|
pubmed:day |
20
|
pubmed:volume |
112
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
78-86
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:15305378-Androgens,
pubmed-meshheading:15305378-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:15305378-Humans,
pubmed-meshheading:15305378-Male,
pubmed-meshheading:15305378-Microscopy, Confocal,
pubmed-meshheading:15305378-Neoplasm Invasiveness,
pubmed-meshheading:15305378-Neoplasms, Hormone-Dependent,
pubmed-meshheading:15305378-Phosphorylation,
pubmed-meshheading:15305378-Precipitin Tests,
pubmed-meshheading:15305378-Prostatic Neoplasms,
pubmed-meshheading:15305378-Receptor, Epidermal Growth Factor,
pubmed-meshheading:15305378-Receptors, Androgen,
pubmed-meshheading:15305378-Signal Transduction,
pubmed-meshheading:15305378-Transfection,
pubmed-meshheading:15305378-Tumor Cells, Cultured
|
pubmed:year |
2004
|
pubmed:articleTitle |
EGF receptor (EGFR) signaling promoting invasion is disrupted in androgen-sensitive prostate cancer cells by an interaction between EGFR and androgen receptor (AR).
|
pubmed:affiliation |
Dipartimento di Fisiopatologia Clinica, Unità di Andrologia, Università di Firenze, Italy.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|